May 24, 2021
INCJ Portfolio company, Atonarp Announces $50M Series D Financing to Scale its Molecular Sensing and Digital Diagnostics Testing Platforms
INCJ Portfolio company, Atonarp, a leading manufacturer of molecular sensing and diagnostics products for the healthcare, pharma, and semiconductor industries, today announced it has raised a $50 million Series D financing, led by WRVI Capital.
Related Press Releases
- Aug 22, 2019
- INCJ to make follow-on investment in Atonarp Inc. Company develops and manufactures miniature equipment for molecular-level composition analysis
- Jul 19, 2016
- INCJ to invest in Atonarp Inc. Company develops and manufactures miniature equipment for molecular-level composition analysis